David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Snap
SNAP
|
+$362M |
| 2 |
Lockheed Martin
LMT
|
+$361M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$354M |
| 4 |
Fidelity National Information Services
FIS
|
+$354M |
| 5 |
Boston Scientific
BSX
|
+$337M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$559M |
| 2 |
Advanced Micro Devices
AMD
|
+$558M |
| 3 |
Boeing
BA
|
+$530M |
| 4 |
Lowe's Companies
LOW
|
+$525M |
| 5 |
Alibaba
BABA
|
+$420M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.94% |
| 2 | Consumer Discretionary | 10.41% |
| 3 | Healthcare | 9.22% |
| 4 | Communication Services | 7.29% |
| 5 | Financials | 6.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3251
Evolent Health
EVH
$534M
| $521K | ﹤0.01% |
32,501
+14,673
| +82% | +$194K |
|
|
ESPR
3252
CALL
DELISTED
Esperion Therapeutics
ESPR
| $520K | ﹤0.01% |
20,000
| – | – |
|
3253
Addus HomeCare
ADUS
$2.26B
| $519K | ﹤0.01% |
4,431
+209
| +5% | +$21.6K |
|
3254
Broadstone Net Lease
BNL
$4.34B
| $519K | ﹤0.01% |
+26,522
| New | +$469K |
|
3255
Sensient Technologies
SXT
$5.85B
| $519K | ﹤0.01% |
7,040
-6,001
| -46% | -$419K |
|
3256
Hormel Foods
HRL
$13.3B
| $518K | ﹤0.01% |
11,123
-453,967
| -98% | -$22.1M |
|
3257
Eagle Bancorp
EGBN
$857M
| $517K | ﹤0.01% |
12,507
-4,668
| -27% | -$164K |
|
3258
National CineMedia
NCMI
$251M
| $517K | ﹤0.01% |
13,907
-3,935
| -22% | -$120K |
|
3259
PUT
Ovintiv
OVV
$18.2B
| $517K | ﹤0.01% |
36,000
| – | – |
|
3260
Cavco Industries
CVCO
$4.48B
| $516K | ﹤0.01% |
+2,942
| New | +$546K |
|
3261
Sony
SONY
$142B
| $516K | ﹤0.01% |
25,510
-36,740
| -59% | -$639K |
|
|
SPWR
3262
PUT
DELISTED
SunPower Corporation Common Stock
SPWR
| $513K | ﹤0.01% |
+20,000
| New | +$404K |
|
3263
Goosehead Insurance
GSHD
$2.59B
| $512K | ﹤0.01% |
+4,102
| New | +$469K |
|
3264
PUT
Allstate
ALL
$65.8B
| $506K | ﹤0.01% |
4,600
+1,300
| +39% | +$128K |
|
3265
MGP Ingredients
MGPI
$384M
| $506K | ﹤0.01% |
+10,744
| New | +$463K |
|
3266
CALL
Hilton Grand Vacations
HGV
$3.53B
| $505K | ﹤0.01% |
16,100
| – | – |
|
3267
PUT
Travelers Companies
TRV
$77.3B
| $505K | ﹤0.01% |
3,600
+500
| +16% | +$64.2K |
|
3268
PUT
Ionis Pharmaceuticals
IONS
$10.3B
| $503K | ﹤0.01% |
8,900
| – | – |
|
3269
Carter Bankshares
CARE
$719M
| $502K | ﹤0.01% |
46,845
+17,787
| +61% | +$151K |
|
|
APHA
3270
DELISTED
Aphria Inc. Common Shares
APHA
| $502K | ﹤0.01% |
72,566
+57,666
| +387% | +$360K |
|
3271
Actinium Pharmaceuticals
ATNM
$32.9M
| $501K | ﹤0.01% |
+64,181
| New | +$697K |
|
3272
Luxfer Holdings
LXFR
$458M
| $499K | ﹤0.01% |
30,395
-7,643
| -20% | -$112K |
|
3273
OSI Systems
OSIS
$3.36B
| $499K | ﹤0.01% |
5,353
-7,774
| -59% | -$665K |
|
3274
Domino's
DPZ
$11.5B
| $498K | ﹤0.01% |
1,300
-29,005
| -96% | -$11.4M |
|
|
SOHU
3275
Sohu.com
SOHU
$379M
| $498K | ﹤0.01% |
31,214
+15,573
| +100% | +$286K |
|
Similar funds
David Shaw's Q4 2020 Portfolio in Review
As of Q4 2020, David Shaw held 4,343 positions worth $112B, up 14% from $97.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $10.3B in Q4 2020, closing 477 positions and reducing 1,508 holdings. Its most notable exit was iShares Gold Trust, an estimated $217M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, David Shaw opened a new position in Snowflake worth $147M.
- David Shaw's largest Q4 2020 buy was Snowflake: 523,721 shares worth $147M.
- David Shaw added most to Snap in Q4 2020, an estimated $362M increase.
- David Shaw's biggest Q4 2020 reduction was Tesla, cutting an estimated $559M.
- David Shaw fully exited iShares Gold Trust in Q4 2020, selling an estimated $217M.
- David Shaw's ten largest holdings make up 11% of its $112B portfolio in Q4 2020.
- David Shaw opened 563 new positions and closed 477 in Q4 2020.
- David Shaw's portfolio value rose 14% quarter-over-quarter to $112B.
Based on D.E. Shaw & Co's 13F filing for Q4 2020, filed 16 Feb 2021.